Tyrosine Kinase Inhibitor - Neonatal Disorders

Relevant Publications

Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.

Issue Release: 2024

Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis.

Issue Release: 2024

A Visual Analysis of the Research Dynamics in Resistance to EGFR Inhibitors for NSCLC.

Issue Release: 2024

Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis.

Issue Release: 2024

The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite.

Issue Release: 2024

Alterations in pharmacogenetic genes and their implications for imatinib resistance in Chronic Myeloid Leukemia patients from an admixed population.

Issue Release: 2024

Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors.

Issue Release: 2024

The CDK9 inhibitor enitociclib overcomes resistance to BTK inhibition and CAR-T therapy in mantle cell lymphoma.

Issue Release: 2024

Impact of structural biology and the protein data bank on us fda new drug approvals of low molecular weight antineoplastic agents 2019-2023.

Issue Release: 2024

A successful complete resection for multidrug-resistant giant gastrointestinal stromal tumor invading the transverse colon with multiple liver metastases in a young female: a case report.

Issue Release: 2024

Antitumor activity of afatinib in EGFR T790M-negative human oral cancer therapeutically targets mTOR/Mcl-1 signaling axis.

Issue Release: 2024

The endocrine disruptor vinclozolin causes endothelial injury via eNOS/Nox4/IRE1α signaling.

Issue Release: 2024

3D layered co-culture model enhances Trastuzumab Deruxtecan sensitivity and reveals the combined effect with G007-LK in HER2-positive non-small cell lung cancer.

Issue Release: 2024

Gastroretentive fibrous dosage forms for prolonged delivery of sparingly-soluble tyrosine kinase inhibitors. Part 3: Theoretical models of drug concentration in blood.

Issue Release: 2024

Histopathological Evidence for a Non-Inflammatory Mechanism in Osimertinib-Induced Myopathy: A Case Report.

Issue Release: 2024

Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials.

Issue Release: 2024

N-phenyl pyrazoline derivative inhibits cell aggressiveness and enhances paclitaxel sensitivity of triple negative breast cancer cells.

Issue Release: 2024

Sunitinib-mediated inhibition of STAT3 in skeletal muscle and spinal cord does not affect the disease in a mouse model of ALS.

Issue Release: 2024

A phase I study of TAK-659 and paclitaxel in patients with taxane-refractory advanced solid tumors.

Issue Release: 2024

Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemia.

Issue Release: 2024

How Does Continuity of Care Impact Chronic Conditions?

What Causes VSD in Neonates?

Why is PSG Important in Pediatrics?

What Specialized Services are Available for Neonatal Disorders?

Why Are Braxton Hicks Contractions Important in Pediatrics?

What is the Prognosis for Newborns with Innocent Murmurs?

How to Measure the Effectiveness of Education?

What is Quality Assurance in Pediatrics?

How can technology improve medication adherence in Pediatrics?

What are Some Challenges in Biomarker Discovery?

Tyrosine Kinase Inhibitor - Neonatal Disorders

Relevant Publications

Partnered Content Networks

Relevant Topics